Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
The Journal of Experimental Medicine|January 1, 1996
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokinesL Zitvogel, J I Mayordomo, T Tjandrawan, et al.The Journal of Gene Medicine|February 7, 2001
Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunityT Tüting, J Steitz, J Brück, et al.Stem Cells (Dayton, Ohio)|January 1, 1997
Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccinesJ I Mayordomo, T Zorina, W J Storkus, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variantsT K Hoffmann, K Nakano, E M Elder, et al.Journal of Neuro-Oncology|January 31, 2002
Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograftD F Stefanik, W K Fellows, L R Rizkalla, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neckM Eura, K Chikamatsu, F Katsura, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1985
A monoclonal antibody that recognizes an Ly-6-linked antigen inhibits the generation of functionally active T cell subsetsP M Flood, D B Murphy, M Horowitz, et al.Cytometry|November 21, 2000
Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complexT K Hoffmann, V S Donnenberg, U Friebe-Hoffmann, et al.Natural Immunity|November 1, 1994
Expression and function of Fc gamma RII on human natural killer cellsD Metes, C Galatiuc, I Moldovan, et al.The Journal of Experimental Medicine|April 1, 1996
Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccinesJ I Mayordomo, D J Loftus, H Sakamoto, et al.Pageof 6